Home › Funds › SWISS RE LTD › ABBV
SWISS RE LTD position in ABBV
ABBVIE INC · Health Care
SWISS RE LTD reported holding 4,790 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.66% of its reported portfolio and ranking #27 among its reported holdings. SWISS RE LTD has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How SWISS RE LTD's ABBV position evolved
SWISS RE LTD first disclosed a stake in ABBV in Q4 2025 at 208 shares (US$48K). The position peaked in Q3 2026 at 4,790 shares, worth US$1.3M. Across 4 filings, SWISS RE LTD increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,790 shares valued at US$1.3M — an increase of 1,875 shares quarter over quarter.. Notable position changes include a 1301% increase in Q2 2026 (shares rose 5% over the following quarter), a 64% increase in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 208 | $47.53K | New |
| Q1 2026 | 208 | $45.24K | Hold |
| Q2 2026 | 2.92K | $733.53K | Add |
| Q3 2026 | 4.79K | $1.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABBV and 13F data
ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 115.40M sh · $29.04B · Q2 2026
- Banque Cantonale Vaudoise 89.31K sh · $22.47B · Q2 2026
- STATE STREET CORP 81.22M sh · $17.66B · Q1 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 48.48M sh · $12.20B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 47.00M sh · $11.81B · Q2 2026
- Geode Capital Management 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
More on SWISS RE LTD
FAQ
How long has SWISS RE LTD held ABBV?
SWISS RE LTD has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is SWISS RE LTD's current position in ABBV?
As of Q3 2026, SWISS RE LTD holds 4.79K shares of ABBV (ABBVIE INC), valued at $1.25M, representing 0.66% of its reported portfolio and ranking #27.
Has SWISS RE LTD been buying or selling ABBV?
In the latest 13F filing (Q3 2026), SWISS RE LTD increased its position in ABBV. The position peaked in Q3 2026 at 4.79K shares.
Which other funds hold ABBV?
Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.